• 1. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 2. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 5. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Quinazolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Benzodiazines Quinazolines

Introduction to Methyl Quinazoline-6-Carboxylate (CAS No. 1234616-24-0)

Methyl quinazoline-6-carboxylate (CAS No. 1234616-24-0) is a significant compound in the field of pharmaceutical chemistry, known for its versatile applications in drug discovery and development. This compound belongs to the quinazoline derivatives, a class of heterocyclic compounds that have garnered considerable attention due to their broad spectrum of biological activities. The molecular structure of methyl quinazoline-6-carboxylate features a quinazoline core substituted with a carboxylate group at the 6-position and a methyl ester group, which contribute to its unique chemical properties and reactivity.

The synthesis of methyl quinazoline-6-carboxylate involves multi-step organic reactions, typically starting from readily available precursors such as anthranilic acid derivatives. The process often includes condensation reactions, cyclization, and esterification steps to achieve the desired product. Advanced synthetic methodologies, including catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been employed to enhance yield and purity. These synthetic strategies are crucial in ensuring that the final product meets the stringent requirements for pharmaceutical applications.

In recent years, methyl quinazoline-6-carboxylate has been extensively studied for its potential pharmacological effects. Research has highlighted its role as a precursor in the synthesis of various bioactive molecules, particularly in the development of antiviral and anticancer agents. The quinazoline scaffold is well-documented for its ability to interact with biological targets such as kinases and DNA polymerases, making it a valuable building block in medicinal chemistry. The carboxylate and methyl ester functionalities further expand its utility by allowing modifications that can fine-tune biological activity and pharmacokinetic properties.

One of the most promising areas of research involving methyl quinazoline-6-carboxylate is its application in antiviral therapies. Studies have demonstrated that derivatives of this compound exhibit inhibitory effects on viral enzymes, thereby reducing viral replication. For instance, modifications at the 6-position carboxylate group have been shown to enhance binding affinity to viral proteases, leading to more effective inhibition. Additionally, the methyl ester group provides a site for further functionalization, enabling the development of prodrugs that improve bioavailability and target specificity.

The anticancer potential of methyl quinazoline-6-carboxylate has also been extensively explored. Preclinical studies indicate that certain derivatives can induce apoptosis in cancer cells by interfering with key signaling pathways involved in cell proliferation and survival. The quinazoline core interacts with enzymes such as tyrosine kinases, which are often overexpressed in cancer cells. By inhibiting these enzymes, methyl quinazoline-6-carboxylate derivatives can disrupt tumor growth and promote cancer cell death. Furthermore, structural analogs have been designed to improve solubility and reduce toxicity, making them more suitable for clinical trials.

Recent advancements in computational chemistry have further accelerated the development of novel derivatives of methyl quinazoline-6-carboxylate. Molecular modeling techniques allow researchers to predict the binding modes of these compounds with biological targets with high accuracy. This approach has enabled the rapid identification of lead compounds that exhibit potent biological activity while minimizing off-target effects. Such computational strategies are integral to modern drug discovery pipelines, providing a cost-effective and efficient means of identifying promising candidates for further investigation.

The industrial production of methyl quinazoline-6-carboxylate adheres to strict quality control measures to ensure consistency and reliability for pharmaceutical applications. Analytical techniques such as high-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry are employed to verify purity and structural integrity. These methods provide detailed information about the chemical composition of the compound, ensuring that it meets regulatory standards before being used in drug formulations.

The future prospects of methyl quinazoline-6-carboxylate in pharmaceutical research are promising. Ongoing studies aim to uncover new therapeutic applications by exploring its interactions with various biological targets. Additionally, green chemistry principles are being integrated into synthetic methodologies to reduce environmental impact while maintaining high yields and purity. Such innovations align with global efforts to develop sustainable practices in drug manufacturing.

In conclusion, methyl quinazoline-6-carboxylate (CAS No. 1234616-24-0) is a versatile compound with significant potential in pharmaceutical research and development. Its unique chemical structure and biological activities make it a valuable precursor for synthesizing antiviral and anticancer agents. Advances in synthetic chemistry, computational modeling, and quality control continue to enhance its utility, paving the way for new therapeutic breakthroughs.

• 31611-50-4(Furo[3,4-f]quinazoline-7,9-dione)
• 953039-79-7(Methyl 2-chloroquinazoline-7-carboxylate)
• 51552-68-2(Methyl quinoline-7-carboxylate)
• 38896-30-9(Methyl quinoline-6-carboxylate)
• 1011-65-0(Methyl indole-5-carboxylate)
• 26663-77-4(1H-Benzimidazole-5-carboxylic Acid Methyl Ester)
• 676326-53-7(Quinazoline-6-carboxylic acid)
• 97931-41-4(Methyl 9H-carbazole-3-carboxylate)
• 50820-65-0(Methyl 1H-indole-6-carboxylate)
• 26000-33-9(Methyl 9H-carbazole-2-carboxylate)